Engineers Gate Manager’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
+13,657
| New | +$151K | ﹤0.01% | 1937 |
|
|
2025
Q1 | – | Sell |
-19,832
| Closed | -$187K | – | 2573 |
|
|
2024
Q4 | $187K | Sell |
19,832
-7,193
| -27% | -$67.7K | ﹤0.01% | 1897 |
|
|
2024
Q3 | $218K | Buy |
27,025
+7,548
| +39% | +$60.8K | ﹤0.01% | 1772 |
|
|
2024
Q2 | $165K | Buy |
19,477
+7,556
| +63% | +$64.1K | ﹤0.01% | 1676 |
|
|
2024
Q1 | $107K | Sell |
11,921
-13,058
| -52% | -$117K | ﹤0.01% | 1736 |
|
|
2023
Q4 | $281K | Buy |
+24,979
| New | +$281K | 0.01% | 1491 |
|
|
2021
Q4 | – | Sell |
-18,482
| Closed | -$137K | – | 2287 |
|
|
2021
Q3 | $137K | Buy |
+18,482
| New | +$137K | 0.01% | 1495 |
|
|
2021
Q1 | – | Sell |
-18,051
| Closed | -$321K | – | 2116 |
|
|
2020
Q4 | $321K | Buy |
+18,051
| New | +$321K | 0.01% | 1257 |
|
|
2020
Q3 | – | Sell |
-73,667
| Closed | -$1.55M | – | 1977 |
|
|
2020
Q2 | $1.55M | Buy |
73,667
+33,046
| +81% | +$694K | 0.08% | 383 |
|
|
2020
Q1 | $939K | Buy |
40,621
+4,886
| +14% | +$113K | 0.07% | 462 |
|
|
2019
Q4 | $925K | Buy |
35,735
+7,891
| +28% | +$204K | 0.04% | 685 |
|
|
2019
Q3 | $542K | Sell |
27,844
-14,627
| -34% | -$285K | 0.03% | 747 |
|
|
2019
Q2 | $694K | Buy |
+42,471
| New | +$694K | 0.04% | 612 |
|
|
2018
Q4 | – | Sell |
-20,262
| Closed | -$662K | – | 1125 |
|
|
2018
Q3 | $662K | Buy |
+20,262
| New | +$662K | 0.05% | 442 |
|